Aimmune Therapeutics, Inc. Company Profile
✉ Email this page to a colleague
Biologic Drugs for Aimmune Therapeutics, Inc.
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
|---|---|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc. | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | 10,029,015 | 2035-05-08 | Patent claims search |
| Aimmune Therapeutics, Inc. | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | 10,040,783 | 2036-11-30 | Patent claims search |
| Aimmune Therapeutics, Inc. | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | 10,064,906 | 2035-12-31 | DrugPatentWatch analysis and company disclosures |
| Aimmune Therapeutics, Inc. | ZENPEP | pancrelipase | Capsule, Delayed Release | 022210 | 10,087,493 | 2029-03-09 | Patent claims search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
